Zobrazeno 1 - 10
of 43
pro vyhledávání: '"B. M. Sandmaier"'
Autor:
Lauri S Burroughs, Ann E. Woolfrey, B. M. Sandmaier, Monica S. Thakar, Rainer Storb, R Pasquini, Carmen Bonfim, Hans-Peter Kiem, Mark C. Walters
Publikováno v:
Bone marrow transplantation
Bone marrow transplantation, vol 52, iss 4
Bone marrow transplantation, vol 52, iss 4
We developed a haploidentical transplantation protocol with post-transplant cyclophosphamide (CY) for in vivo T-cell depletion using a novel adapted-dosing schedule (25 mg/kg on days +3 and +4) for Fanconi Anemia. With median follow-up of 3 years (ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82036a8f7c8bfd98a23019a67ffed573
https://doi.org/10.1038/bmt.2016.301
https://doi.org/10.1038/bmt.2016.301
Autor:
B. M. Sandmaier, Rainer Storb, Ann E. Woolfrey, H. J. Deeg, Lisandro Ribeiro, Hans-Peter Kiem, Paul O'Donnell, Ricardo Pasquini, Carmem Bonfim, Mary E.D. Flowers, Ted Gooley, Monica S. Thakar
Publikováno v:
Pediatric Hematology and Oncology. 29:568-578
Allogeneic hematopoietic cell transplantation (HCT) is the only known cure for patients with Fanconi Anemia (FA) who develop aplasia or leukemia. However, transplant regimens typically contain high-dose alkylators, which are poorly tolerated in FA pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a593f54a786c4ed4b5e833d7c196d3c
https://doi.org/10.3109/08880018.2012.708708
https://doi.org/10.3109/08880018.2012.708708
Autor:
FR Appelbaum, Richard A. Nash, George E. Sale, KA Rouleau, T de Revel, PM Wallace, Peter F Moore, L Krizanac-Bengez, Peter A. McSweeney, M Beauchamp, L. Bolles, B. M. Sandmaier, Rainer Storb
Publikováno v:
Blood. 88:1992-2003
Increasingly, enriched populations of hematopoietic progenitors are used in experimental and clinical transplantation studies. The separation of progenitors is based on the expression of CD34, a marker preferentially expressed on progenitor cells. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d687e4b889b79197649d74d4b59419f6
https://doi.org/10.1182/blood.v88.6.1992.bloodjournal8861992
https://doi.org/10.1182/blood.v88.6.1992.bloodjournal8861992
Autor:
Cong Yu, T Lian, Peter A. McSweeney, Friedrich Schuening, B. M. Sandmaier, Erlinda B. Santos, Rainer Storb, Theodore C. Graham, L Krizanac-Bengez, H. J. Deeg
Publikováno v:
Blood. 87:3508-3513
We have studied graft-versus-host disease (GVHD) after transplantation of allogeneic peripheral blood stem cells (PBSC) mobilized by either recombinant canine granulocyte colony-stimulating factor (rcG-CSF) alone or combined with stem cell factor (rc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c020cf702bda3e125d3526168fe645b
https://doi.org/10.1182/blood.v87.8.3508.bloodjournal8783508
https://doi.org/10.1182/blood.v87.8.3508.bloodjournal8783508
Publikováno v:
The Journal of Immunology. 150:812-820
In this study, we examined the in vitro effect of an anti-CD44 mAb, S5, on NK function using canine PBMC as effectors. S5 enhanced NK activity in a dose-dependent and rapid fashion as did IM7, another anti-CD44 mAb that recognizes a common epitope(s)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38bdee0980eda8ae90c77e44f6af4183
https://doi.org/10.4049/jimmunol.150.3.812
https://doi.org/10.4049/jimmunol.150.3.812
Autor:
Fisher, Howard M. Shulman, Rainer Storb, Theodore C. Graham, Paul A. Brown, Friedrich Schuening, FR Appelbaum, JA Bianco, B. M. Sandmaier, H. J. Deeg
Publikováno v:
Blood. 80:1608-1613
166Holmium ethylenediaminetetramethylene phosphonic acid (166Ho-EDTMP) is a short-lived beta-emitting radionuclide complexed to an aminophosphonate ligand that we have investigated in a canine model as a potential agent for specific marrow ablation b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::587afb1946b1e10cf67ca506054fe4e1
https://doi.org/10.1182/blood.v80.6.1608.1608
https://doi.org/10.1182/blood.v80.6.1608.1608
Autor:
H T, Greinix, W C, Ladiges, T C, Graham, S, Maslan, R F, Raff, B M, Sandmaier, F R, Appelbaum, F G, Schuening, H J, Deeg, R, Storb
Publikováno v:
Blood. 78:2131-2138
We established a model of canine marrow autografts after 9.2 Gy total body irradiation (TBI) to study the role of class II antigens in hematopoietic stem cell growth and differentiation. Twenty dogs were given 9.2 Gy TBI, marrow, and intravenous (IV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a723dc8491495988daac02ddbb39cff2
https://doi.org/10.1182/blood.v78.8.2131.bloodjournal7882131
https://doi.org/10.1182/blood.v78.8.2131.bloodjournal7882131
Publikováno v:
Blood. 76:630-635
Pretreatment of recipients with the monoclonal antibody (MoAb) S5 facilitates engraftment of bone marrow from mismatched, unrelated donors in the canine transplantation model. In the direct comparisons reported here, the S5 glycoprotein (gp) was foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfe5de6c795a3e27b327b03c0e73aaf0
https://doi.org/10.1182/blood.v76.3.630.630
https://doi.org/10.1182/blood.v76.3.630.630
Publikováno v:
Blood. 76:630-635
Pretreatment of recipients with the monoclonal antibody (MoAb) S5 facilitates engraftment of bone marrow from mismatched, unrelated donors in the canine transplantation model. In the direct comparisons reported here, the S5 glycoprotein (gp) was foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7af46eab62701387f07736a14d9da7c
https://doi.org/10.1182/blood.v76.3.630.bloodjournal763630
https://doi.org/10.1182/blood.v76.3.630.bloodjournal763630
Autor:
F. Benedetti, Francesco Onida, Andrea Riccardo Filippi, P. Di Bartolomeo, Daniele Mattei, Bernardino Allione, P Bavaro, Marco Casini, Marcello Rotta, Luisa Giaccone, Benedetto Bruno, Luca Castagna, Giorgio Lambertenghi-Deliliers, Michele Falda, Enrico Pogliani, A. Levis, Ileana Baldi, Mario Boccadoro, M.P. Iori, Alessandro Rambaldi, Robert Foa, Roberto Sorasio, Francesca Patriarca, Antonio Palumbo, Vittorio Montefusco, B. M. Sandmaier, Rainer Storb, Matteo Parma, David G. Maloney, Massimo Aglietta, F. Fiore, Nicola Mordini, Alessandro Busca, Paolo Corradini, Fabrizio Carnevale-Schianca, R Fanin, M. Petrini, Umberto Ricardi
The development of nonmyeloablative conditionings has recently reduced the transplant-related mortality (TRM) and extended the eligible age for transplantation up to 65–70 years. From January 2000 to June 2005, 106 newly diagnosed patients younger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5199712555d54c5bafc0fbf5527f92ea
http://hdl.handle.net/2318/100764
http://hdl.handle.net/2318/100764
